The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Petelina T.I.

Filial FGBU "NII kardiologii SO RAMN" Tiumenskiĭ kardiologicheskiĭ tsentr

Musikhina N.A.

Filial FGBU "NII kardiologii SO RAMN" Tiumenskiĭ kardiologicheskiĭ tsentr

Gapon L.I.

Filial FGBU "NII kardiologii SO RAMN" Tiumenskiĭ kardiologicheskiĭ tsentr

Dement'eva N.V.

Filial FGBU "NII kardiologii SO RAMN" Tiumenskiĭ kardiologicheskiĭ tsentr

Lystsova N.L.

Filial FGBU "NII kardiologii SO RAMN" Tiumenskiĭ kardiologicheskiĭ tsentr

Takkand A.G.

Filial FGBU "NII kardiologii SO RAMN" Tiumenskiĭ kardiologicheskiĭ tsentr

Petrashevskaia T.G.

Filial FGBU "NII kardiologii SO RAMN" Tiumenskiĭ kardiologicheskiĭ tsentr

Zyrianov I.P.

Filial FGBU "NII kardiologii SO RAMN" Tiumenskiĭ kardiologicheskiĭ tsentr

Blood chemistry analysis in patients with coronary heart disease: prospective observation after transluminal balloon angioplasty

Authors:

Petelina T.I., Musikhina N.A., Gapon L.I., Dement'eva N.V., Lystsova N.L., Takkand A.G., Petrashevskaia T.G., Zyrianov I.P.

More about the authors

Read: 925 times


To cite this article:

Petelina TI, Musikhina NA, Gapon LI, et al. . Blood chemistry analysis in patients with coronary heart disease: prospective observation after transluminal balloon angioplasty. Russian Journal of Cardiology and Cardiovascular Surgery. 2013;6(5):17‑21. (In Russ.)

References:

  1. Vertkin A.L., Prokhorovich E.A., Kul'nichenko T.V. Rol' statinov v lechenii bol'nykh s ostrym koronarnym sindromom bez pod''ema segmenta ST. Rus med zhurn 2010; 22: 1315.
  2. Gavrilenko T.I., Sokolov Yu.N., Kornilina E.M. Rol' infektsii i faktorov immunnogo vospaleniya v razvitii restenozov u bol'nykh so stabil'noi stenokardiei. Ukrains'kii medichnii chasopis 2002; 4: 59-62.
  3. Lysova N.L., Trusov O.A., Belyakov M.M. i dr. Rol' vospaleniya pri ateroskleroze koronarnykh arterii serdtsa. Vestn RGMU 2010; 1: 25-27.
  4. Skorobogatova Yu.V. Pokazateli vospaleniya, lipidnogo obmena i polimorfizm gena apoproteina (a) v otsenke techeniya ishemicheskoi bolezni serdtsa u patsientov posle koronarnogo stentirovaniya: Avtoref. dis. kand. med. nauk. SPb 2008.
  5. Teplyakov A.T., Rybal'chenko E.V., Aptekar' V.D. i dr. Retsidivy stenokardii posle stentirovaniya koronarnykh arterii: vliyanie dislipidemi. Byul SO RAMN 2006; 1: 13-17.
  6. Tsereteli N.V., Rakhimov A.Z. Izmenenie parametrov vospalitel'nogo otveta i pokazatelei endotelial'noi funktsii posle koronarnogo stentirovaniya u bol'nykh IBS. Vestn RAMN (CD-prilozhenie) 2008; 6: 462.
  7. Shevchenko O.P., Prirodova O.F. Ateroskleroz kak sistemnoe vospalitel'noe zabolevanie s volnoobraznoi generalizovannoi aktivnost'yu protsessa. Vestn RGMU 2010; 1: 28-33.
  8. Shevchenko O.P., Shevchenko A.O., Kuntsevich N.V. i dr. Assotsiirovannyi s beremennost'yu protein plazmy RARR-A i urovni markerov vospaleniya u bol'nykh ishemicheskoi bolezn'yu serdtsa. Vestn RGMU 2010; 1: 34-40.
  9. Berliner J.A., Haberland M.E. The role of oxidized low-density lipoprotein in atherogenesis. Curr Opin Lipid 2003; 4: 373-381.
  10. Bhakdi S., Torzewski M., Klouche M., Hemmes M. Complement and atherogenesis. Binding of CRP to degraded, nonoxidized LDL enhances complement activation. Arterioscler Thromb Vasc Biol 1999; 19: 2348-2354.
  11. Danesh J., Collins R., Peto R. et al. Lipoprotein (a) and Soronary Heart Disease. Meta-analysis of prospective studies . Circulation 2000; 120: 1082-1085.
  12. Danesh J., Wheeler J.G., Hirschfield G.M. et al. C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease. New Engl J Med 2004; 350: 1387-1397.
  13. Discepolo W., Wun T., Berglund L. Lipoprotein(a) and thrombocytes: potential mechanisms underlying cardiovascular risk. Pathophysiol Haemost Thromb 2006; 35: 3-4: 314-321.
  14. Erbel R., Ge J., Bockisch A. et al. Value of intracoronary ultrasound and Doppler in the differentiation of angiographically normal coronary arteries: a prospective study in patients with angina pectoris. Eur Heart J 1996; 17: 880-889.
  15. Ford E.S. Does exercise reduce inflammation? Physical activity and C-reactive protein among U.S. adults. Epidemiology 2002; 13: 5: 561-568.
  16. Ford E.S., Giles W.H. Serum C-reactive protein and self-reported stroke. Findings from the Third National Health and Nutrition Examination Survey. Arteriocler Thromb Vasc Biol 2000; 20: 1052-1056.
  17. Garvin P., Nilsson L., Carstensen J. et al. Circulating matrix metalloproteinase-9 is associated with cardiovascular risk factors in a middle-aged normal population. Oxford J Med 2008; 101: 10: 785-791.
  18. Hartmann M., von Birgelen C., Mintz G.S. et al. Relation between lipoprotein(a) and fibrinogen and serial intravascular ultrasound plaque progression in left main coronary arteries. J Am Coll Cardiol 2006; 48: 3: 446-452.
  19. Landau C., Lange R.A., Hillis L.D. Percutaneous transluminal coronary angioplasty. N Engl J Med 1994; 330: 981-993.
  20. Memon L., Spasojevic-Kalimanovska V. et al. Association of C-reactive protein with the Presense and Extent of Angiographically Verified Coronary Artery Disease. Tohoku J Exp Med 2006; 209: 197-206.
  21. Posano G.M., Gebara O., Fini M. et al. The increased plasma levels of C-reactive protein following oral hormone replacement therapy are not related to an increased inflammatory response. J Am Coll Cardiol 2001; 37: 256.
  22. Ribichini F., Steffenino G., Dellavalle A. et al. On line quantitative coronary analysis in clinical practice: one step closer to reality? Cathet Cardiovasc Diagn 1994; 31: 100-102.
  23. Ridker P.M. Clinical application of C-reactive protein for cardiovascular disease detection and prevention. Circulation 2003; 107: 363-369.
  24. Stein J.H., Rosenson R.S. Lipoprotein Lp (a) excess and coronary heart disease. Arch Int Med 1997; 157: 1170-1176.
  25. Tatura M.C., Heinrich J., Junker R. et al. C-reactive protein and the severity of atherosclerosis in myocardial infarction patients with stable angina pectoris. Eur Heart J 2000; 21: l000-1008.
  26. Tanowitz H.B., Huang H., Jelicks L.A. et al. Role of endothelin-1 in the pathogenesis of chronic chagasic heart disease. Infect Immun 2005; 73: 2496-2503.
  27. Zwaka T.P., Hombach V., Torzewski J. C-reactive protein-mediated low density lipoprothein uptake by macrophages. Circulation 2001; 103: 1194-1197.
  28. Vogel R.A. Coronary risk factors, endothelial function, and atherosclerosis: a review. Clin Cardiol 1997; 20: 5: 426-432.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.